DiscoverThe BellcastFrom the helm: Starpharma's (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley
From the helm: Starpharma's (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

From the helm: Starpharma's (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Update: 2022-11-08
Share

Description

In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma's (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.

 Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:

  • (0:56 ) A brief overview of Starpharma
  • (2:31 ) Growing distribution network for Viraleze
  • (3:29 ) SPL's exciting oncology portfolio and key partnerships with major companies
  • (4:56 ) How Viraleze works and the market opportunity going forward
  • (6:09 ) What's coming up next for SPL
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

From the helm: Starpharma's (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

From the helm: Starpharma's (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley